PEOPLE - Akers Bioscience (UK) makes appointment:
This article was originally published in Clinica
Executive Summary
Akers Bioscience (London, UK), a developer of POC tests, has appointed Geoffrey Osborne Vero to the board. Mr Vero has substantial experience of the private equity industry.